Matches in Wikidata for { <http://www.wikidata.org/entity/Q90068763> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q90068763 description "artículu científicu espublizáu en xunu de 2017" @default.
- Q90068763 description "scientific article published on 01 June 2017" @default.
- Q90068763 description "wetenschappelijk artikel" @default.
- Q90068763 description "наукова стаття, опублікована в червні 2017" @default.
- Q90068763 name "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 name "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 type Item @default.
- Q90068763 label "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 label "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 prefLabel "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 prefLabel "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 P1433 Q90068763-AD67DBA2-D72A-4139-A300-5D8AA1737FE6 @default.
- Q90068763 P1476 Q90068763-D916D6D0-B31A-44BF-8F82-FCBBAEC62AD3 @default.
- Q90068763 P2093 Q90068763-08397875-1642-479D-BBFD-72CD36D14C5C @default.
- Q90068763 P2093 Q90068763-301B981F-F2C1-423B-9107-621E6B63EC33 @default.
- Q90068763 P2093 Q90068763-38F3C0C0-F803-453E-97DC-003E3B74F3BD @default.
- Q90068763 P2093 Q90068763-527F4212-36F7-4A25-BA30-A50C8199B62B @default.
- Q90068763 P2093 Q90068763-5FBB971B-1B92-4B3C-8B08-CDC5B0F03943 @default.
- Q90068763 P2093 Q90068763-68DCCA7A-DC4C-4E82-84A6-A0C7CCF8BC36 @default.
- Q90068763 P2093 Q90068763-724AE7B4-D09D-487A-A035-ADBB795BCD7B @default.
- Q90068763 P2093 Q90068763-B3B8DC0A-5A87-4617-9138-5F289FE896E0 @default.
- Q90068763 P2093 Q90068763-B42C71EA-3116-404C-A971-9EA6CEAE0421 @default.
- Q90068763 P2093 Q90068763-D1A3D809-A34A-46F7-B000-4036FACBF620 @default.
- Q90068763 P2093 Q90068763-D65F0E31-BBA8-4670-A49D-A1B174D405C9 @default.
- Q90068763 P2093 Q90068763-DFCA6A1A-361E-4BCD-A156-8F1E126C481C @default.
- Q90068763 P2093 Q90068763-E598539E-E5BA-480D-867E-F08F48CFA9EA @default.
- Q90068763 P2093 Q90068763-F0BEED0E-4043-475D-A227-05D370885953 @default.
- Q90068763 P2093 Q90068763-F6253EE5-90C8-4DDA-81F4-6069489AF863 @default.
- Q90068763 P2093 Q90068763-F71BD8B0-67FC-4A33-9613-915D30B132ED @default.
- Q90068763 P2093 Q90068763-FBC1B75B-4F72-470E-A274-A34A399BC8D1 @default.
- Q90068763 P304 Q90068763-1E3BACA9-2717-43DA-B1D3-3428575085E5 @default.
- Q90068763 P31 Q90068763-4DA02EC7-1754-4AFA-8C5E-7F91F743A4AA @default.
- Q90068763 P356 Q90068763-36E2D460-97C3-4B26-B461-2926A241EB20 @default.
- Q90068763 P478 Q90068763-CD866B46-1C97-4CCD-A911-5A2E4B161601 @default.
- Q90068763 P577 Q90068763-6B0E5481-0D11-4B0C-BBE7-CA34E887B908 @default.
- Q90068763 P921 Q90068763-CB1F6F34-008C-4E22-A013-83F90BCC2741 @default.
- Q90068763 P921 Q90068763-F028765B-177C-453E-9A45-290CD70DB97F @default.
- Q90068763 P356 MDX302.001 @default.
- Q90068763 P1433 Q326122 @default.
- Q90068763 P1476 "A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)" @default.
- Q90068763 P2093 "A Neki" @default.
- Q90068763 P2093 "A Noonan" @default.
- Q90068763 P2093 "A Sehdev" @default.
- Q90068763 P2093 "A Starodub" @default.
- Q90068763 P2093 "B El-Rayes" @default.
- Q90068763 P2093 "B O'Neil" @default.
- Q90068763 P2093 "C J Li" @default.
- Q90068763 P2093 "C Oh" @default.
- Q90068763 P2093 "K Ciombor" @default.
- Q90068763 P2093 "L Borodyansky" @default.
- Q90068763 P2093 "S Mikhail" @default.
- Q90068763 P2093 "S Shahda" @default.
- Q90068763 P2093 "T Bekaii-Saab" @default.
- Q90068763 P2093 "W Hanna" @default.
- Q90068763 P2093 "W Li" @default.
- Q90068763 P2093 "W Shaib" @default.
- Q90068763 P2093 "Y Z Li" @default.
- Q90068763 P304 "iii150" @default.
- Q90068763 P31 Q13442814 @default.
- Q90068763 P356 "10.1093/ANNONC/MDX302.001" @default.
- Q90068763 P478 "28 Suppl 3" @default.
- Q90068763 P577 "2017-06-01T00:00:00Z" @default.
- Q90068763 P921 Q18556189 @default.
- Q90068763 P921 Q19000961 @default.